
DSM receives registration approval for SYN-UP® as a New Cosmetic Ingredient (NCI) in China
25 Jan 2023
Royal DSM, a global purpose-led science-based company, today announces that its skin care peptide SYN-UP® has been approved as a New Cosmetic Ingredient (NCI) in China under the country’s new cosmetic legislation and can be used freely in formulations all over the world. The outcome makes DSM the first company to receive NCI approval in the stringent NCI category 3 and confirms that SYN-UP® meets the highest levels of quality and safety for an active peptide